Accuray Incorporated (ARAY)
NASDAQ • Healthcare
Last close at October 22, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Accuray Incorporated currently loses $2.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 4
in 13 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Accuray’s revenue missed expectations in the fourth fiscal quarter of 2026, with preliminary results reported August 19, 2026 showing revenue of $100.9 million trailing the $105.3 million estimate (-4.2%) and falling 20.9% from $127.5 million a year ago, reflecting weaker topline performance across its radiation treatment equipment and software business, including systems such as CyberKnife and TomoTherapy. Despite the revenue decline, profitability at the gross line held up, with gross profit of roughly $35.5 million translating to a gross margin of about 35%, while operating results remained negative with operating income of around -$7.1 million and an operating margin near -7%. The quarter generated about $2.4 million of operating cash flow. For the next period, consensus calls for EPS of -$0.07 on revenue of $95.8 million.
Next report — what to expect
Accuray Incorporated (ARAY) reports earnings on November 4, 2026. Wall Street is looking for consensus EPS of -$0.07 on revenue of $95.8 million. For trailing context, revenue fell -20.9% year over year last quarter. The company has beaten EPS in 3 of its 8 most recent quarters.
About Accuray Incorporated
Accuray Incorporated (NASDAQ: ARAY) makes radiation treatment equipment and software for the healthcare market, specializing in radiosurgery and radiation therapy systems used to treat tumors. In FY2026, the company generated $401.9 million in revenue. Its business sits within medical technology, selling capital equipment, planning tools, and related services to care providers.
Today's Snapshot
ARAY closed 3.7% lower at 0.13, against a firmer sector. ARAY reports earnings on 4 November.
Trading Volume
Below 10d avg (2.4M)
2.2M
vs S&P 500 Today
Underperforming Market
-2.46%
Updated: October 22, 2026 at 20:28 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$0.17 - $0.46Sell
- RSI (14)25.82Buy
- Stochastic %K (14, 3, 3)3.02Buy
- MACD Level (12, 26)-0.03Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.